Turnover of the biopharmaceutical sector in the United Kingdom 2017, by segment

This statistic displays the annual turnover of the biopharmaceutical sector in the United Kingdom (UK) in 2017, by segment. The biopharmaceutical sector researches and produces pharmaceutical medications which are extracted or semi-synthesized from a biological source. These can include vaccines, antibodies, blood and tissue products and therapeutic proteins. The turnover of the small molecules segment was approximately 27 billion British pounds in 2017, the largest turnover in this year. This was followed by the therapeutic proteins segment at approximately 1.8 billion British pounds. The segment with the lowest turnover in 2017 was the advanced therapy medicinal products segment at 293 million British pounds.